BRAF and melanoma: As an additional mechanism of action, vemurafenib stimulates NO• and O2•− production and it also induces depolarization of mitochondrial membranes in BRAF V600E-mutated melanoma cells, potentially initiating apoptosis and growth inhibition [54, 55].